MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.250
+0.010 (0.81%)
At close: Apr 28, 2026, 4:00 PM EDT
1.280
+0.030 (2.40%)
Pre-market: Apr 29, 2026, 8:06 AM EDT
MAIA Biotechnology Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -22.4 | -23.25 | -19.77 | -16.22 | -12.5 | |
| Other Amortization | - | - | - | - | 0.6 | |
| Stock-Based Compensation | 2.63 | 1.91 | 3.09 | 2.32 | 2.72 | |
| Other Operating Activities | -0.58 | 6.88 | 0.53 | 1.45 | 3.94 | |
| Change in Accounts Payable | 0.52 | -0.12 | 0.47 | 0.21 | 0.81 | |
| Change in Other Net Operating Assets | 0.98 | -1.12 | 2.61 | 0.14 | 0.32 | |
| Operating Cash Flow | -18.84 | -15.7 | -13.07 | -12.1 | -4.12 | |
| Long-Term Debt Issued | - | - | - | - | 7.43 | |
| Short-Term Debt Repaid | - | - | - | - | -0 | |
| Total Debt Repaid | - | - | - | - | -0 | |
| Net Debt Issued (Repaid) | - | - | - | - | 7.43 | |
| Issuance of Common Stock | 18.52 | 18.97 | 11.42 | 14.44 | 6.6 | |
| Other Financing Activities | -0.62 | -0.8 | -2.15 | -1.97 | - | |
| Financing Cash Flow | 17.91 | 18.18 | 9.27 | 12.48 | 14.03 | |
| Foreign Exchange Rate Adjustments | -0.01 | -0.02 | -0 | -0 | - | |
| Net Cash Flow | -0.94 | 2.45 | -3.8 | 0.38 | 9.91 | |
| Levered Free Cash Flow | -11.02 | -9.93 | -7.42 | -7.43 | -1.59 | |
| Unlevered Free Cash Flow | -11.02 | -9.93 | -7.41 | -7.43 | -1.67 | |
| Change in Working Capital | 1.5 | -1.24 | 3.09 | 0.35 | 1.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.